In the BioHarmony Drug Report Database

"Preview" Icon

Voriconazole

Vfend, Voriconazole (voriconazole) is a small molecule pharmaceutical. Voriconazole was first approved as Vfend on 2002-03-19. It is used to treat aspergillosis, candidiasis, fusariosis, and mycoses in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses.

 

Trade Name

 

Vfend
 

Common Name

 

voriconazole
 

ChEMBL ID

 

CHEMBL638
 

Indication

 

aspergillosis, bacterial infections and mycoses, candidiasis, fusariosis, mycoses
 

Drug Class

 

Systemic antifungals (miconazole type)

Image (chem structure or protein)

Voriconazole structure rendering